AB
Allison Bratzel Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
15
Avg Return
Past Year
Past Year
22%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
83.3%
Neutral
16.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $30 |
304%
upside
| 1 | -13% |
0
%
| 11 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $930 |
16%
upside
| 1 | +9.4% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $35 |
26%
upside
| 1 | – |
–
| 4 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $77 |
1%
upside
| 1 | +37% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $102 |
4%
downside
| 1 | +4.6% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $3 |
497%
upside
| 1 | -51% |
0
%
| 22 Oct ‘25 2 months ago |
|